593 related articles for article (PubMed ID: 8633143)
21. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices.
Kamimura K; Fukukura Y; Yoneyama T; Takumi K; Tateyama A; Umanodan A; Shindo T; Kumagae Y; Ueno S; Koriyama C; Nakajo M
J Magn Reson Imaging; 2014 Oct; 40(4):884-9. PubMed ID: 24677659
[TBL] [Abstract][Full Text] [Related]
22. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
Schuhmann-Giampieri G; Schmitt-Willich H; Press WR; Negishi C; Weinmann HJ; Speck U
Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695
[TBL] [Abstract][Full Text] [Related]
23. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
[TBL] [Abstract][Full Text] [Related]
24. Increased detection of intracranial metastases with intravenous Gd-DTPA.
Healy ME; Hesselink JR; Press GA; Middleton MS
Radiology; 1987 Dec; 165(3):619-24. PubMed ID: 3317496
[TBL] [Abstract][Full Text] [Related]
25. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
[TBL] [Abstract][Full Text] [Related]
26. Dynamic MR imaging of the liver with Gd-DTPA: initial clinical results.
Edelman RR; Siegel JB; Singer A; Dupuis K; Longmaid HE
AJR Am J Roentgenol; 1989 Dec; 153(6):1213-9. PubMed ID: 2816634
[TBL] [Abstract][Full Text] [Related]
27. MR imaging evaluation of liver enhancement by Gd-EOB-DTPA in selective and total bile duct obstruction in rats: correlation with serologic, microcholangiographic, and histologic findings.
Ni Y; Marchal G; Lukito G; Yu J; Mühler A; Baert AL
Radiology; 1994 Mar; 190(3):753-8. PubMed ID: 8115623
[TBL] [Abstract][Full Text] [Related]
28. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
29. MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR; Press GA
Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
[TBL] [Abstract][Full Text] [Related]
30. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N
Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
[TBL] [Abstract][Full Text] [Related]
31. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
[TBL] [Abstract][Full Text] [Related]
32. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
34. Dynamic MR imaging of liver metastases with Gd-EOB-DTPA.
Stern W; Schick F; Kopp AF; Reimer P; Shamsi K; Claussen CD; Laniado M
Acta Radiol; 2000 May; 41(3):255-62. PubMed ID: 10866081
[TBL] [Abstract][Full Text] [Related]
35. Focal liver lesion detection and characterization with GD-EOB-DTPA.
Purysko AS; Remer EM; Veniero JC
Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
[TBL] [Abstract][Full Text] [Related]
36. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ
Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960
[TBL] [Abstract][Full Text] [Related]
37. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
Svaland MG; Christensen T; Lundorf E
Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392
[TBL] [Abstract][Full Text] [Related]
40. Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA.
Schmitz SA; Häberle JH; Balzer T; Shamsi K; Boese-Landgraf J; Wolf KJ
Radiology; 1997 Feb; 202(2):399-405. PubMed ID: 9015065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]